BibTex RIS Cite

Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı

Year 2008, Volume: 39 Issue: 2, 73 - 75, 20.07.2014

Deniz Göksedef Suat Ömeroğlu Şeyma Denli Cenk Üreyen Cem Sayılgan Gökhan İpek

Keywords

Sistemik lupus eritematozus aort kapak replasmanı aort yetmezliği

References

  • Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus. A review. J Thorac Cardiovasc Surg 1983; 85: 718-726.
  • Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93:1579-1587.
  • Kumar S, Sinha B, Ravikumar E. Emergency aortic valve replacement in systemic lupus erythematosus. Heart Lung Circ 2006; 15: 397-399.
  • Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797-1804.
  • Nobrega TP, Klodas E, Breen JF, et al. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cadiovasc Diagn 1996; 39: 75-79.
  • Sharma AK, Farb A, Maniar P, et al. Spontaneous coronary artery dissection in a patient with systemic lupus erythematosis. Hawaii Med J 2003; 62: 248-253.
  • Schattner A, Liang MH. The cardiovascular burden of lupus: a complex challenge. Arch Intern Med 2003;163: 1507-1510.
  • Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-2415.
  • Boumpas DT, Austin HA III, Fessler BJ, et al. Systemic lupus erythematosus: emerging concepts. Ann Intern Med 1995; 122: 940-950.
  • Hahn BH. Systemic lupus erythematosus and accelerated atherosclerosis. N Engl J Med 2004; 349: 2379-2380.
  • Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399–2406.
  • Roldan CA, Shively BK, Crawford MH. An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus. N Engl J Med 1996; 335: 1424-1430.
  • Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
  • Jonsson CA, Svensson L. Beneficial effect of the inosine monophosphate Dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice. Clin Exp Immunol 1999;116: 534-541.

Year 2008, Volume: 39 Issue: 2, 73 - 75, 20.07.2014

Deniz Göksedef Suat Ömeroğlu Şeyma Denli Cenk Üreyen Cem Sayılgan Gökhan İpek

References

  • Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus. A review. J Thorac Cardiovasc Surg 1983; 85: 718-726.
  • Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93:1579-1587.
  • Kumar S, Sinha B, Ravikumar E. Emergency aortic valve replacement in systemic lupus erythematosus. Heart Lung Circ 2006; 15: 397-399.
  • Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797-1804.
  • Nobrega TP, Klodas E, Breen JF, et al. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cadiovasc Diagn 1996; 39: 75-79.
  • Sharma AK, Farb A, Maniar P, et al. Spontaneous coronary artery dissection in a patient with systemic lupus erythematosis. Hawaii Med J 2003; 62: 248-253.
  • Schattner A, Liang MH. The cardiovascular burden of lupus: a complex challenge. Arch Intern Med 2003;163: 1507-1510.
  • Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-2415.
  • Boumpas DT, Austin HA III, Fessler BJ, et al. Systemic lupus erythematosus: emerging concepts. Ann Intern Med 1995; 122: 940-950.
  • Hahn BH. Systemic lupus erythematosus and accelerated atherosclerosis. N Engl J Med 2004; 349: 2379-2380.
  • Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399–2406.
  • Roldan CA, Shively BK, Crawford MH. An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus. N Engl J Med 1996; 335: 1424-1430.
  • Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
  • Jonsson CA, Svensson L. Beneficial effect of the inosine monophosphate Dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice. Clin Exp Immunol 1999;116: 534-541.
There are 14 citations in total.

Details

Primary Language Turkish
Journal Section Olgu Sunumları
Authors

Deniz Göksedef This is me

Suat Ömeroğlu This is me

Şeyma Denli This is me

Cenk Üreyen This is me

Cem Sayılgan This is me

Gökhan İpek This is me

Publication Date July 20, 2014
Published in Issue Year 2008 Volume: 39 Issue: 2

Cite

APA Göksedef, D., Ömeroğlu, S., Denli, Ş., Üreyen, C., et al. (2014). Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı. Cerrahpaşa Tıp Dergisi, 39(2), 73-75.
AMA Göksedef D, Ömeroğlu S, Denli Ş, Üreyen C, Sayılgan C, İpek G. Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı. Cerrahpaşa Tıp Dergisi. July 2014;39(2):73-75.
Chicago Göksedef, Deniz, Suat Ömeroğlu, Şeyma Denli, Cenk Üreyen, Cem Sayılgan, and Gökhan İpek. “Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı”. Cerrahpaşa Tıp Dergisi 39, no. 2 (July 2014): 73-75.
EndNote Göksedef D, Ömeroğlu S, Denli Ş, Üreyen C, Sayılgan C, İpek G (July 1, 2014) Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı. Cerrahpaşa Tıp Dergisi 39 2 73–75.
IEEE D. Göksedef, S. Ömeroğlu, Ş. Denli, C. Üreyen, C. Sayılgan, and G. İpek, “Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı”, Cerrahpaşa Tıp Dergisi, vol. 39, no. 2, pp. 73–75, 2014.
ISNAD Göksedef, Deniz et al. “Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı”. Cerrahpaşa Tıp Dergisi 39/2 (July 2014), 73-75.
JAMA Göksedef D, Ömeroğlu S, Denli Ş, Üreyen C, Sayılgan C, İpek G. Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı. Cerrahpaşa Tıp Dergisi. 2014;39:73–75.
MLA Göksedef, Deniz et al. “Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı”. Cerrahpaşa Tıp Dergisi, vol. 39, no. 2, 2014, pp. 73-75.
Vancouver Göksedef D, Ömeroğlu S, Denli Ş, Üreyen C, Sayılgan C, İpek G. Sistemik Lupus Eritematozuslu Bir Olguda Aort Yetmezliği Nedeniyle Aort Kapak Replasmanı. Cerrahpaşa Tıp Dergisi. 2014;39(2):73-5.